Stem cell treatment for patients diagnosed with Amyotrophic lateral sclerosis (ALS)
ALS is progressive disease, which means that symptoms get worse over time, therefore it’s not curable. However, a patient diagnosed with ALS can benefit from stem cell treatment, improve the overall quality of his life, and even expand it for 6 to 8 months. Bearing in mind the severity of the disease, Swiss Medica clinic offers STEM CELL TREATMENT for patients diagnosed with Amyotrophic lateral sclerosis (ALS), hoping that somehow we can contribute to improving their condition. We learned a lot about ALS and tried to treat this disease using a combination of stem cells, different procedures and so on. As a result, we have a method, which helps to prolong life and improve symptoms.
Amyotrophic Lateral Sclerosis (ALS) treatment with stem cells
Amyotrophic lateral sclerosis (ALS) is a severe progressive disease of the nervous system. Despite more than a century of its study, ALS development causes remain unclear. This disease is characterized by the degeneration of motor neurons, which take place in the spinal cord and brain, resulting in muscles motor paralysis in the later stages of the condition. Its origin lies in the development of muscle weakness that causes ALS with muscular frame atrophy. Prognosis is extremely poor and until recently, the treatments were symptomatic and could only delay fatal ending.
Pic. 1. Cellular and molecular processes mediating neurodegeneration in ALS
The mechanisms underlying neurodegeneration in ALS are multifactorial and operate through inter-related molecular and genetic pathways. Specifically, neurodegeneration in ALS might result from a complex interaction of glutamate excitoxicity, generation of free radicals, cytoplasmic protein aggregates, SOD1 enzymes, combined with mitochondrial dysfunction, and disruption of axonal transport processes through accumulation of neurofilament intracellular aggregates. Mutations in TARDBP and FUS result in formation of intracellular aggregates, which are harmful to neurons. Activation of microglia results in secretion of proinflammatory cytokines, resulting in further toxicity. Ultimately, motor neuron degeneration occurs through activation of calcium-dependent enzymatic pathways. Our doctors recommend you individual treatment program and offer the best stem cells.
ALS and stem cells
In recent years, there has been a breakthrough in the ALS therapy. Numerous studies have demonstrated how ALS is treated by the positive effect of stem cell therapy. Stem cells are represented by cells that have not undergone differentiation and acquired specific functions. They have the self-healing capacity by dividing and differentiating into specific cell types. Being a part of human repair system naturally, it is only logical that this is a powerful source in fighting damaged areas in organism. Mature or differentiated cells used for the treatment of degenerative diseases, which include amyotrophic lateral sclerosis, form specific structures and perform specific functions and in many cases, lose the ability to divide and reproduce which is the basis of stem cell therapy for ALS.
The use of this innovative method increases the release level of neurotrophic substances by mesenchymal steam cell therapy. The neurotrophic substances protect motor neurons against damage, contribute to its formation and improve the neuromuscular interaction. This is the first therapy of mesenchymal stem cells use. The method basis lies in the use of patient’s own stem cells found in bone marrow or fat tissue, which are used for the neurons grown in the laboratory. The entire treatment process is up to the highest technological and medical standards. The risk of treatment by Adult Autologous Stem Cell is minimal and limited to the normal risks of surgical intervention. Because the used cells are patient’s own, there is no risk of rejection or side effects. The treatment by own steam cells can significantly slow down the ALS symptoms and prolong patient’s life. The limb movement increases, muscle tension and fasciculations zones number decreases, reflexes normalize, better tolerability of daily stress is introduced, as well as swallowing and word pronunciation, which also improve.
ALS stem cell therapy opens entirely new possibilities in the disease treatment, resulting in the significant improvement of patient’s motor activity with mental and emotional status. In addition, overall health is at a much higher level. Numerous clinical trials and personal experience of ALS treatment using autologous hematopoietic stem cells proved the to be absolutely safe.
Currently, this therapy is considered the most modern and effective treatment method for ALS, which has been successfully applied in practice in the European clinic with the highest reputation, Swiss Medica.
The following is a list of diseases treated by stem cell therapy in our clinic:
- — Erectile dysfunction
- — Amyotrophic lateral sclerosis
- — Alzheimer disease
- — Parkinson’s disease
- — Macular degeneration
- — Diabetes (type 1 and 2)
- — Apoplexy
- — Spinal cord injury
- — Multiple sclerosis
- — Cardiovascular disease
- — Cerebral paralysis
- — Orthopedic diseases
ALS stem cells treatment in Swiss Medica Clinic
Our clinic has developed the program of Adult Autologous Stem Cell Therapy treating a variety of conditions, one of them being ALS. During the treatment, patient receives 200-300 million cells. This procedure is very safe, painless, quick and simple and it is completed within only a couple of hours. Small quantity of stem cells are taken from the patient’s body, either from bone marrow or fat tissue, depending on a person. After the substance is professionally separated and activated, stem cells are put back into the patient’s body using a standard IV dip. Now comes the resting stage, during which stem cells circulate the body looking for the place of damage and slowly start the repairing process. Improvements can be visible very soon, but are still building up in the next 2-4 months. This treatment works like no other, improving the symptoms, but reversing them as well.
However, besides treating the suffering areas, stem cells make the whole body healthier and more rejuvenated. The amount of plain restored cells exceeds the person’s daily losses by thousand times. Because of it, all organs in the body are renewed and old and damaged cells replaced.
Swiss Medica ХХI Century has been working for 20 years and our successful clinical experience made each individual in our team experts in restoration and revitalization of the body. Our specialists prevent a number of serious age related and chronic diseases. Working with modern technologies, we are constantly improving our knowledge, developing skills and approaches in this field.
We take into consideration the patient’s state, his or hers analyses and disease history
The advantages of our treatment system:
- Side effects and rejection free (patient’s very own stem cells from the abdomen and/or bone marrow are used).
- Avoidance of any allergic and immune reactions (patient’s own cells suit chromosomal and genetic structure).
- Does not require general anesthesia.
- No risk of contamination by transmissible diseases.
- No oncological complications as adult stem cells in the comparison to embryonic cells are rather mature.
- Procedure is very quick and simple. Small quantity of cells are extracted from bone marrow and/or fat tissue. Combination of the two can often show the best results.
- The period of time between getting lipoaspirate and injection of the activated stem cells is only a few hours.
- Adult stem cells are superior over embryonic stem cells, because they don’t require growth of several moths and come from patient’s own body, which is why there is no risk of side effects after the treatment.
At Swiss Medica Clinic we deliver the treatment with proven results associated with the assistance of highly qualified professionals who realize the importance of personalized care, quality and confidence that guarantees the top standards of treatment.
A patient can undergo medical treatment in Swiss Medica ХХI Century in Moscow (Russia), Belgrade (Serbia) or Switzerland.
